SEO URLwww.firestrike.ai/deals/mbiomics-series-a-funding-2026
fundraiseAnnounced · Apr 29, 2026Biotherapeutics
mbiomics
mbiomics raises €30M in Series A
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Raise amount
€30M
Company
mbiomics
Round
—
Lead investor
—
mbiomics raised €30M in a Series A round. Sector: Biotherapeutics. Location: Munich, Germany.
This page summarizes publicly available information about the round as of 2026-04-29. Figures may change as press releases and filings update.
mbiomics has completed the third and final tranche of its Series A funding round, raising €12 million to build its own manufacturing facilities for complex microbial products.
Deal timeline
Announced
Apr 29, 2026 · techfundingnews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotherapeutics with a reported deal value of €30M. Figures and status may change as sources update.
Sources: techfundingnews.com · Primary article · FireStrike proprietary index